AT&T Misses on Revenue from Cheaper Tablet Data Fees

Michael Teague  |

AT&T (T) reported net income for the first quarter of $3.7 billion, or $0.67 per share on revenue of $31.36 billion.

Adjusted earnings, excluding the sale of an advertising business, were at $0.64 per share, above the $0.60 earned in the prior-year period, and exactly what analysts had predicted.

Revenue, however, was nearly half a billion less than analyst expectations of $31.74 billion, and less than the prior year period when the company brought it $31.82 billion.

The company added 296,000 devices to contract-based plans, but all in the form of tablets carrying lower monthly fees. Overall, the AT&T posted its first ever loss on contract-based plans, and, excluding tablets, lost contract-based devices to the tune of 69,000.

This created a situation in which average revenue per contract user rose only 0.9 percent for Q1.

Company CFO John Stephens recognized the role of tablets in the decrease in spending for the period, noting that the company’s cheap data plans for the devices are not set in stone. “We put that in place to see how it would work, to stimulate demand,” but later in the conference call said that it was not necessarily a “permanent offering.”

The company’s shares closed regular trading at $39 on a slight gain of 0.7 percent, but slipped 1.54 in afterhours to $38.40.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
GPAC PRPL Global Partner Acquisition Corp. n/a n/a n/a n/a
T AT&T Inc. 30.47 0.68 2.28 37,188,658 Trade

Comments


Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     
BA

     
WMT

     
DIS

     
XOM

     

Can the Media Solve the Partisan Conflict?

Andrew McCarthy, Contributing Editor, The National Review; Michael Zeldin, CNN Legal Analyst; Celeste Katz, Senior Political Reporter, Glamour; Silvia Davi, SVP, Contributing Editor, Equities.com; and Doug Simon, CEO, D S Simon Media discuss how the media’s role has shaped the landscape for communicators and what the media is trying to do to reduce discord in society.

Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.